文献速递头颈外科咽喉与嗓音

KUSCC-192:韩国扁桃体癌患者来源的混合型HPV扁桃体鳞癌细胞系

KUSCC-192: A Novel Tonsillar Squamous Cell Carcinoma Cell Line With Mixed (Episomal and Integrated)-Typed Human Papillomavirus From a Korean Patient With Tonsil Cancer.
PubMed 文献 · Head Neck · 2025-12-30

研究建立了来自韩国扁桃体癌患者的HPV阳性扁桃体鳞癌细胞系KUSCC-192,经RT-qPCR、RT-PCR和FISH检测显示其为混合型(游离与整合型)HPV,以弥漫型FISH信号为主并伴少量点状信号,E2基因表达较低。该细胞系表现出侵袭性特征,提示混合型HPV整合可能解释2%-30%HPV阳性HNSCC患者预后较差的现象。

要点

  • KUSCC-192是新型HPV阳性扁桃体鳞癌细胞系,HPV为混合型(游离与整合型)
  • 该细胞系FISH以弥漫型信号为主伴少量点状信号,E2基因表达较低
  • 混合型HPV整合可能与部分HPV阳性HNSCC侵袭性及不良预后相关

核心结论

  • KUSCC-192是研究侵袭性HPV阳性头颈鳞癌行为的有价值模型。
  • 混合型HPV整合在HNSCC中的临床意义尚需进一步研究。

研究设计与样本

  • 研究建立了来自韩国扁桃体癌患者的HPV阳性扁桃体鳞癌细胞系KUSCC-192并评估其致瘤性。
  • 采用RT-qPCR、RT-PCR和FISH检测KUSCC-192的HPV状态。
  • 将KUSCC-192的侵袭性特征与其他HPV阳性细胞系及HPV阴性细胞系进行比较。

主要发现

  • KUSCC-192的FISH呈现混合型,以弥漫型为主并伴少量点状信号。
  • KUSCC-192的E2基因表达较低。
  • KUSCC-192具有侵袭性特征。
  • 上述发现提示混合型可能解释2%-30%HPV阳性HNSCC病例的不良预后。

关键数值与推荐

  • HPV阳性HNSCC总体预后较好,但部分病例具侵袭性且结局差。
  • HPV阳性HNSCC中约2%-30%病例预后不良。

临床怎么用

  • KUSCC-192可作为研究侵袭性HPV阳性扁桃体癌行为的细胞模型。
  • 对HPV阳性HNSCC应关注混合型HPV整合状态与侵袭性表型的关联。

局限性

  • 混合型HPV整合在HNSCC中的临床意义尚需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Human papillomavirus-positive (HPV+) head and neck squamous cell carcinoma (HNSCC) generally has a better prognosis, but some cases are aggressive with poor outcomes. This study established KUSCC-192, a de novo HPV+ tonsillar cancer cell line, and evaluated its tumorigenicity. METHOD: The HPV status in KUSCC-192 was assessed using RT-qPCR, RT-PCR, and FISH. Aggressive characteristics were compared with other HPV+ cell lines and HPV- cell lines. RESULT: KUSCC-192 exhibited a mixed type with a predominantly diffused FISH pattern and a few dotted signals and lower E2 gene expression. These findings, combined with its aggressive features, suggest that the mixed type may contribute to the poor prognosis observed in 2%-30% of HPV+ HNSCC cases. CONCLUSION: KUSCC-192 is a valuable model to study aggressive HPV+ cancer behaviors. Further research is needed to explore the clinical significance of mixed-type HPV integration in HNSCC.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Kim JH, Moon JH, Kim CY, et al. KUSCC-192: A Novel Tonsillar Squamous Cell Carcinoma Cell Line With Mixed (Episomal and Integrated)-Typed Human Papillomavirus From a Korean Patient With Tonsil Cancer. Head Neck. 2025. PMID: 41467388. doi:10.1002/hed.70143

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。